
PepHaūs Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.6/10
Best for: all-inclusive compounded GLP-1 pricing shipped nationwide
PepHaūs stands out for its medical oversight and the pharmacy behind it.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
PepHaūs is a telehealth pharmacy offering compounded GLP-1 weight-loss treatment: semaglutide at $169/mo and tirzepatide at $239/mo billed monthly, or $152 and $215 a month on a 6-month plan. Treatment is prescribed by U.S.-licensed providers and shipped from 503A compounding pharmacies. Its pitch is all-inclusive pricing: the medication, medical visit, and shipping are bundled into one cost at any dose. It also offers NAD+, sermorelin, and glutathione alongside weight loss.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to PepHaūs
Direct Meds
Best for: listed for disclosure only; see its FDA warning and BBB complaints first
Editorial score · methodology
Maximus
Best for: men seeking compounded GLP-1 alongside testosterone optimization
Editorial score · methodology
Editorial score · methodology
PepHaūs at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $169/mo
- What's included
- Medication · Consult · Shipping
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How we scored PepHaūs
Each dimension is scored algorithmically from PepHaūs’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
7.3/10At $169/mo, PepHaūs runs about 6% below the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide).
Effectiveness25%
8.0/10PepHaūs offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.3/10Online intake and platform experience (consult included in the price); 6 platform features disclosed.
Trust & Safety15%
8.7/10Key details fully confirmed by our editors; no FDA warning letters on file; dispenses through an accredited compounding pharmacy.
Accessibility10%
8.2/10PepHaūs treats patients in all 50 states.
Support10%
5.8/10PepHaūs provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this PepHaūs review
Last checked October 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: high.
What we checked
- Provider's own pricing page
- $169–$239/mo across 2 dose/plan tiers (checked July 2026)
- State pharmacy licensing & LegitScript status
- LegitScript Verified
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with PepHaūs
We walked PepHaūs’s public signup flow in July 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Complete an online intake form.
- 2A U.S.-licensed provider reviews your information (stated ~24-hour turnaround).
- 3If approved, the prescription is filled by a licensed pharmacy.
- 4Medication ships direct-to-door with free expedited shipping.
- Transparent pricing shown upfront: semaglutide $169/mo and tirzepatide $239/mo billed monthly; the 'from $152' and 'from $215' headlines are the 6-month plan rate. The site says 'every price is on the site.'
- Full refund with no charge for the visit if you are deemed ineligible.
- Cancel or pause anytime from the account dashboard or by emailing hello@thepephaus.com.
- Free expedited shipping on all orders, direct-to-door.
- Eligibility stated: BMI 30+, or 27+ with weight-related conditions; BMI 25+ may qualify per provider assessment.
PepHaūs customer support
- hello@thepephaus.com
GLP-1 medications PepHaūs offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Peptides PepHaūs offers
Beyond GLP-1s, PepHaūs also offers these peptides. Tap any for our evidence-based guide.
Pricing
Prices re-verified
Month-to-month, billed monthly; one fixed price at any dose, provider visit and shipping included. Quarterly plan $160/mo (billed $481.65 every 3 months); 6-month plan $152/mo (billed $912.60).
Month-to-month, billed monthly; one fixed price at any dose, provider visit and shipping included. Quarterly plan $227/mo; 6-month plan $215/mo (billed $1,291).
Ready to get started?
Plans and promotions change often, so check PepHaūs's current pricing and active discounts before you decide.
What we like
- All-inclusive pricing: medication, medical visit, and shipping bundled into one cost
- Compounded semaglutide $169/mo and tirzepatide $239/mo billed monthly, one price at any dose ($152 and $215 on a 6-month plan)
- LegitScript-certified (#50233613); 503A-compounded medication
- Ships to all 50 states from U.S.-licensed 503A pharmacies
- Quick online intake with 24-hour provider review
Watch-outs
- Compounding pharmacy partners aren't named on the marketing site
- Pricing is customized per patient, so your final cost can vary from the advertised 'from' rates
- No published individual clinician or medical-director names
- Newer multi-vertical brand (also NAD+, sermorelin, glutathione) with a limited weight-loss track record
Is PepHaūs worth it?
What PepHaūs is selling, in one line, is all-inclusive compounded GLP-1 pricing shipped nationwide. It runs $169/month, squarely in the middle of what this category charges, so what you get for it matters more here than the number itself. It treats patients in every state, so where you live isn't a reason to rule it out.
Beyond the medication itself, PepHaūs fills through a 503A pharmacy and is LegitScript-certified.
How much PepHaūs costs
Compounded semaglutide runs $169/month and compounded tirzepatide runs $239/month.
That's roughly in line with the ~$179/month median across the GLP-1 providers we track (each program's lowest listed ongoing monthly price for compounded semaglutide).
For a direct comparison, HealthRX runs semaglutide and tirzepatide from $165/month, so compare it with PepHaūs before you commit.
Medications: what PepHaūs prescribes
PepHaūs prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro), the two most-studied weight-loss molecules on the market today. The medication is compounded at a licensed pharmacy rather than sold as a brand pen, which is what keeps the price down. The trade-off is the one every compounded provider shares: compounded drugs aren't FDA-approved as finished products.
Who PepHaūs is best for, and who should skip it
A good fit if you…
- live anywhere in the US and want the certainty that your state is already covered.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen instead of a compounded formulation, which this provider doesn't fill.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
PepHaūs treats patients in all 50 states, and dispenses through an accredited compounding pharmacy, and we found no FDA warning letter on file for it. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation, and we explain how in our scoring methodology.
Bottom line
PepHaūs is a reasonable telehealth GLP-1 option; weigh its pricing and coverage against the alternatives below before deciding.
The Bottom Line
PepHaūs stands out for its medical oversight and the pharmacy behind it.
Ready to start with PepHaūs?
From $169/mo. See current pricing and start your free consultation.
PepHaūs might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare PepHaūs vs…
PepHaūs scores7.6/10
Side-by-side pricing, medications and scores. Pick a matchup.
PepHaūs vs Amazon One Medical
Amazon One Medical scores 8.5/10

PepHaūs vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this PepHaūs review:
Sources & methodology (as of October 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See PepHaūs's current pricing
Plans from $169/mo. Start your free consultation to check eligibility and today's price.